Hanny Al-samkari, Md
Clinical trials sponsored by Hanny Al-samkari, Md, explained in plain language.
-
New hope for cancer patients: drug may prevent chemo delays from low platelets
Disease control OngoingThis study tests whether the drug avatrombopag can safely raise low platelet counts caused by chemotherapy in people with gastrointestinal cancers. About 60 adults will receive either avatrombopag or a placebo. The goal is to see if the drug helps patients keep their platelet cou…
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated May 26, 2026 11:33 UTC
-
Can a cancer drug stop chronic nosebleeds? new trial for HHT patients
Disease control OngoingThis study tests whether bevacizumab, a drug that blocks a protein involved in abnormal blood vessel growth, can reduce chronic bleeding and iron-deficiency anemia in people with hereditary hemorrhagic telangiectasia (HHT). HHT causes fragile blood vessels that bleed easily, ofte…
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated May 26, 2026 11:08 UTC